Antiviral Drug Discovery

As part of a $65M NIH grant towards new direct acting antivirals, seven job opportunities are available in Professor Matthew Todd's group at UCL in central London. 

 

These exciting roles represents a rare and exciting opportunity to join an outstanding group of scientists to join UCL for a long-term project that will make a major international contribution to our pandemic preparedness through basic research. We are now hiring for:

 

Four Synthetic Chemistry Research Fellows are needed to design, make and procure small molecules. 

 

One Protein Science Research Fellow is needed to develop and establish protein binding assays for novel antiviral targets. 

 

One Project Manager is required to manage the local team and liaise with the broader consortium on delivery of aims. 

 

One Laboratory Manager is required to maintain the local research environment and liaise with external vendors. 

 

Details of all positions may be found at https://github.com/mattodd/blog/issues/7. 

 

The team, working closely with colleagues at the University of North Carolina, Chapel Hill, constitutes the Medicinal Chemistry Core of the READDI-AViDD consortium that aims to improve our preparedness through the design and validation of small molecule binders of proteins from viruses of pandemic potential. 

 

This major open science consortium includes academic and pharma collaborators from across the world. 

 

Funding is secured to April 2025, with the possibility of extension for a further two years. 

 

Closing date Feb 28^th, 2023 - 23:59 (UK time).

 

Informal queries can be sent to Prof Todd at matthew.todd@ucl.ac.uk.